Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

导出原文传递

翻译打印收藏纠错

作者： Fucikova, Jitka ^[1] ; Truxova, Iva ^[2] ; Hensler, Michal ^[3] ; Becht, Etienne ^[4] ; Kasikova, Lenka ^[5] ; Moserova, Irena ; Vosahlikova, Sarka ; Klouckova, Jana ; Church, Sarah E. ; Cremer, Isabelle ; Kepp, Oliver ; Kroemer, Guido ; Galluzzi, Lorenzo ; Salek, Cyril ; Spisek, Radek

作者单位： Inst Hematol & Blood Transfus, Prague, Czech Republic ^[1] Sotio, Jankovcova 1518-2, Prague 17000 7, Czech Republic ^[2] Ctr Rech Cordeliers, INSERM, U1138, Paris, France ^[3] 1st Fac Med, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic ^[4] Charles Univ Prague, Dept Immunol, Fac Med 2, Prague, Czech Republic ^[5]

发布时间 2017-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood

2016年128卷26期

3113-3124页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

Blood

相似文献

Blood

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

Blood

相似文献

Blood

相关期刊

检索历史清除